
Genetic Technologies for Hemophilia
Explore the science behind genetic technologies for hemophilia in this four-part video series from the WFH. Learn the basics of
Year: 2020
Language: English
Author(s): World Federation of Hemophilia
Format: Video
Listen to this 45-minute webinar presented on 9 November 2020 to learn more about the World Federation of Hemophilia (WFH) Gene Therapy Registry (GTR).
Barbara Konkle, MD (WFH Board of Directors), Glenn Pierce, MD, PhD (WFH VP Medical) and Wolfgang Miesbach, MD (GTR Steering Committee member) discuss the protocol and core data set, the implementation plan, and the timeline of the GTR. The webinar also includes a Q&A session.
To download a pdf of the slides of the webinar, click the icon below.

Explore the science behind genetic technologies for hemophilia in this four-part video series from the WFH. Learn the basics of

The WFH Guidelines for the Management of Hemophilia: AAV Gene Therapy provide the first comprehensive, evidence-based recommendations to support the

This document is an introductory guide for people with hemophilia who wish to join the World Federation of Hemophilia (WFH)

This document is an introductory guide for people with hemophilia who wish to join the World Federation of Hemophilia (WFH)

The World Federation of Hemophilia (WFH) Gene Therapy Registry (GTR) welcomes the participation of all Hemophilia Treatment Centres (HTCs) involved

The World Federation of Hemophilia (WFH) Gene Therapy Registry (GTR) welcomes the participation of all Hemophilia Treatment Centres (HTCs) involved